VANI Vivani Medical, Inc. logo

VANI Vivani Medical, Inc.

Healthcare
$1.20+3.45%ClosedMarket Cap: $70.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

5.11

P/S

0.00

EV/EBITDA

-2.54

DCF Value

$-0.05

FCF Yield

-37.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-264.0%

ROA

-64.0%

ROIC

-74.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-6.8M$
Q4 null$0.00$-6.6M$
FY null$0.00$-26.6M$
Q3 null$0.00$-6.5M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Buy
2026-03-31
HC Wainwright & Co.Buy
2025-09-02

Trading Activity

Insider Trades

View All
Williams Greggdirector, 10 percent owner:
BuyTue May 19
Williams Greggdirector, 10 percent owner:
BuyThu Apr 16
Williams Greggdirector, 10 percent owner:
BuyMon Mar 16
Williams Greggdirector, 10 percent owner:
BuyMon Mar 16
Williams Greggdirector, 10 percent owner:
BuyTue Feb 17

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

2.35

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Peers